Back
NovoCure Stock Price Chart

Is it possible to have a crash proof portfolio?
See important Reg A disclosures: Masterworks.com/cd
Sell
36
NVCR
NovoCure
Last Price:
58.45
Seasonality Move:
26.26%
7 Day Trial
ALL ACCESS PASS
$
7

Get Free, Instant Access To Today's Top Stocks List!
View this list for FREE now!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NovoCure Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.72 | Sell |
20-day SMA: | 72.22 | Sell |
50-day SMA: | 83.49 | Sell |
200-day SMA: | 77.8 | Sell |
8-day EMA: | 64.35 | Sell |
20-day EMA: | 71.15 | Sell |
50-day EMA: | 77.58 | Sell |
200-day EMA: | 80.99 | Sell |
NovoCure Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.29 | Sell |
Relative Strength Index (14 RSI): | 23.63 | Sell |
Chaikin Money Flow: | 1174827 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.63 - 83.49) | Sell |
Bollinger Bands (100): | (69.28 - 89.56) | Sell |
NovoCure Technical Analysis
Mar-7 | Mar-8 | Mar-9 | Mar-10 | Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NovoCure Stock
Is NovoCure Stock a Buy?
- NovoCure share price is 58.45 while NVCR 8-day simple moving average is 64.72, which is a Sell signal.
- The stock price of NVCR is 58.45 while NovoCure 20-day SMA is 72.22, which makes it a Sell.
- NovoCure 50-day simple moving average is 83.49 while NVCR share price is 58.45, making it a Sell technically.
- NVCR stock price is 58.45 and NovoCure 200-day simple moving average is 77.80, creating a Sell signal.
NVCR Technical Analysis vs Fundamental Analysis
NovoCure Stock Info
Market Cap:
6.16B
Price in USD:
58.45
Share Volume:
1.29M
NovoCure 52-Week Range
52-Week High:
120.03
52-Week Low:
56.39
Sell
36
NovoCure (NVCR)
is a Sell
NovoCure Share Price Forecast
-
What is the NovoCure stock price today?
The NovoCure stock price is 58.45 USD today. -
Will NVCR stock go up or go down?
NovoCure> share price is forecast to RISE/FALL based on technical indicators -
Is NovoCure overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure is overvalued.
Is NovoCure Stock a Buy?
- NovoCure share price is 58.45 while NVCR 8-day exponential moving average is 64.35, which is a Sell signal.
- The stock price of NVCR is 58.45 while NovoCure 20-day EMA is 71.15, which makes it a Sell.
- NovoCure 50-day exponential moving average is 77.58 while NVCR share price is 58.45, making it a Sell technically.
- NVCR stock price is 58.45 and NovoCure 200-day simple moving average is 80.99, creating a Sell signal.
Fundamental Analysis of NovoCure
Is NovoCure a good investment?
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.16 per share.
Technical Analysis of NovoCure
Should I short NovoCure stock?
- NVCR Moving Average Covergence Divergence (MACD) indicator is -6.29, suggesting NovoCure is a Sell
- NovoCure Relative Strength Index (RSI) is 23.63, which suggest NovoCure is oversold
- The Bollinger Bands (25) for NovoCure is (66.63 - 83.49), which suggest NovoCure is a Sell
- The Bollinger Bands (100) for NovoCure is (69.28 - 89.56), which suggest NovoCure is a Sell
* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.